Insider Trading May 19, 2026 09:04 PM

Gene Yoon-Linked Entities Sell Shares of Neptune Insurance; Valuation and Outlook Under Scrutiny

Transactions involving key affiliates signal ongoing activity for the insurance giant, amid analyst upgrades and profitability transition.

By Hana Yamamoto NP

Entities associated with Gene Yoon, a managing partner at Bregal Sagemount Management LP, reported significant sales of Neptune Insurance Holdings Inc. (NASDAQ:NP) Class A Common Stock over May 2026. These transactions occurred against a backdrop of the company transitioning toward profitability, coupled with recent analyst price target increases and discussions regarding valuation.

Gene Yoon-Linked Entities Sell Shares of Neptune Insurance; Valuation and Outlook Under Scrutiny
NP

Key Points

  • <li class="key-point">Entities linked to Gene Yoon sold a total of $139.3 million worth of Neptune Insurance stock in May 2026.</li>
  • <li class="key-point">Despite recent analyst upgrades (e.g., Raymond James raising the target to $30.00), some analysis suggests the company may be overvalued at current price levels.</li>
  • <li class="key-point">Neptune Insurance is transitioning toward profitability, with analysts forecasting $0.55 per share in 2026 earnings, despite reporting a loss of $0.21 per share over the previous twelve months.</li>

Entities linked to Gene Yoon, Managing Partner at Bregal Sagemount Management LP, recently disclosed substantial sales of Neptune Insurance Holdings Inc. (NASDAQ:NP) Class A Common Stock. These transactions totaled approximately $139.3 million over two dates in May 2026, with all shares sold at a consistent price point of $26.40 per share.

The initial sale took place on May 15, 2026. On this date, BSIV Hold 101, LP, which possesses a 10% ownership stake in Neptune Insurance, disposed of 4,589,351 shares of the Class A Common Stock. The proceeds from this single transaction amounted to roughly $121.0 million.

A subsequent disposition occurred on May 19, 2026. BSIV Hold 101, LP sold an additional 688,403 shares of the Class A Common Stock. This second sale generated approximately $18.2 million and was executed as part of the underwriters’ exercise of their over-allotment option related to a public offering.

The reported sales are notable given that Neptune Insurance currently trades at $26.70, which is near the average sale price of $26.40. However, an analysis from InvestingPro suggests that despite its recent transactions and positive developments, Neptune may be overvalued based on current market levels.


Corporate Structure and Ownership Details

The securities in question are held directly by BSIV Hold 101, LP. This entity is managed by BSIV Hold 101 GP, LLC, which serves as its general partner. The management of BSIV Hold 101 GP, LLC is overseen by Bregal Sagemount IV General Partner Jersey Limited. Crucially, this ultimate controlling entity is 100% owned by Gene Yoon. Furthermore, Bregal Sagemount Management LP, an entity majority-owned by Gene Yoon, functions as the investment advisor to BSIV Hold 101, LP.

The reporting individuals have issued a disclaimer stating that they do not claim beneficial ownership of the reported securities, except for any portion related to their personal pecuniary interest.

Following these dispositions, BSIV Hold 101, LP's direct holding of Neptune Insurance Class A Common Stock was reduced to 14,252,718 shares.


Company Fundamentals and Market Activity

The timing of these significant share sales occurs as Neptune approaches a phase of increased profitability. The company maintains a substantial market capitalization of $3.77 billion. While the financial records show a loss of $0.21 per share over the preceding twelve months, analysts have issued forecasts predicting earnings of $0.55 per share for 2026.

In separate recent corporate news, Neptune Insurance Holdings Inc. announced details regarding a secondary offering. This involved pricing 9,841,395 shares of Class A common stock at $27.50 per share. These shares are being sold by particular selling securityholders, and the company itself will not receive any proceeds from this specific sale.

Despite Neptune not receiving funds from the secondary offering, the company has plans to repurchase 984,140 shares from the underwriters at $26.40 per share, with these repurchased shares slated for retirement. Additionally, Neptune Insurance intends to purchase another 835,561 shares from the underwriters at the same price paid to the selling securityholders, which is contingent upon standard closing conditions.


Analyst Sentiment and Valuation Adjustments

The valuation of Neptune continues to be a subject of active adjustment among financial analysts. Raymond James recently elevated its price target for Neptune Insurance. The firm raised its target from $24.00 to $30.00, while maintaining an Outperform rating.

Similarly, Evercore ISI also increased its price target, adjusting it from $30.00 to $31.00. This upgrade was attributed by the analysts to a solid quarter's performance, despite some concerns raised among investors regarding a margin miss and only a modest increase in the outlook for 2026.

These collective actions, including analyst upgrades and internal share transactions, underscore ongoing adjustments concerning both Neptune Insurance’s valuation and its future financial trajectory. The pattern of sales from key affiliated parties, coupled with positive earnings forecasts and price target increases, presents a complex picture for market observers assessing the company's current worth.


Key Takeaways